glp-1 news past 2 days use rises GLP-1 Drugs: 6 Things We've

A new study published in April sheds light on the concerns of anesthesiologists across the United States related to the perioperative management of patients taking glucagon-like peptide-1 (GLP-1) agonists, a class of drugs now commonly prescribed for both diabetes and cosmetic weight loss

Here's what clinicians should know.

A Cautionary Tale of Fleeting Fortunes and Structural Blind Spots

Bad breath can develop during GLP-1 therapy, but it's usually manageable with simple oral hygiene adjustments

This builds on what we already know: menopause fundamentally alters metabolism

Heres how investors can approach this potentially huge opportunity.